Latest News

iSpecimen Supports Hospital Validation of New Chemistry Analyzer Ready to Announce with Confidence?

Levi & Korsinsky Urges Taboola.com Ltd. (TBLA) Shareholders to Act Before Lead Plaintiff Deadline October 20, 2026

Sankamap Expands Exploration Footprint at Fauro as Systematic Prospecting Advances and New Gold Targets Emerge Ready to Announce with Confidence?

Tessera Sets 2027 Revenue Target of $14–16 Million and Outlines Path to Approximately $30 Million by 2029

Maine Community Bank Partners with Cetera Financial Institutions to Support Growth of Its Wealth Management Program

Telitacicept Demonstrates Deep and Durable Minimal Symptom Expression Through 48 Weeks in Generalized Myasthenia Gravis

Arlo Debuts Essential Solar Security Camera Designed for Year-Round, Low-Maintenance Protection

Silexion Therapeutics Announces Exercise of Warrants

Johnson & Johnson presents new data reinforcing sustained disease control and improved daily function achieved with IMAAVY® (nipocalimab-aahu) in generalized myasthenia gravis (gMG)

Professor Bill Sessa, Former Chief Scientific Officer of Internal Medicine at Pfizer, Appointed Chair of Isomab's Scientific Advisory Board